Medpace Holdings (MEDP) Non-Current Assets (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Non-Current Assets came in at $1.0 billion in Q2 2026, down 4.18% on a YoY basis from $1.1 billion in Q2 2025, and up 1.65% quarter-over-quarter from $990.6 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Non-Current Assets (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Non-Current Assets for 12 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 4.18% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $4.0 billion (down 5.9% YoY), and the FY2025 full-year result was $985.8 million, down 8.01% from the prior year.
- Non-Current Assets rose to $1.0 billion in Q2 2026 per MEDP's latest filing, from $990.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2025 and bottomed at $985.8 million in Q4 2025.
- Historically, Non-Current Assets has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets increased 7.67% in 2022, then decreased 8.01% in 2025.
- Over 5 years, Non-Current Assets stood at $1.0 billion in 2022, then advanced by 4.37% to $1.1 billion in 2023, then increased by 0.81% to $1.1 billion in 2024, then slipped by 8.01% to $985.8 million in 2025, then grew by 2.14% to $1.0 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.0 billion, $990.6 million, and $985.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.65 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 6.00 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 14.00 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3.66 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 990.56 Mn |
| Dec 31, 2025 | 985.85 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 1.05 Bn |
| Mar 31, 2025 | 1.08 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.05 Bn |
| Mar 31, 2024 | 1.05 Bn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 1.03 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Sep 30, 2022 | 990.68 Mn |
| Jun 30, 2022 | 986.57 Mn |
| Mar 31, 2022 | 988.38 Mn |
| Dec 31, 2021 | 969.02 Mn |
| Sep 30, 2021 | 935.92 Mn |